comparemela.com

Page 3 - Paul Glasziou News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Catastrophic decision to defund healthcare advice organisation leaves Australians at risk, say experts | Health

The public will be left more susceptible to medical misinformation and harm, doctors and academics say

New zealandNew south walesPaul glasziouMark butlerKirsten mccafferyBarbara mintzesAndrew knightInstitute for evidencePractice respiratory infections networkSchool of pharmacyUniversity of sydney health literacy labAustralian commission on safetyQuality in health careUniversity of sydney charles perkins centreAustralian commissionHealth care

Professor Paul Glasziou on the long-term impacts of COVID-19

With easing restrictions, vaccinations and low fatality rates, it’s easy to assume the worst of the […]

Paul glasziouAllan boydCommunity broadcastingBond university professor of evidenceUniversity professorEvidence based medicine paul glasziouThe record

Jury s in for ivermectin: No clinical significance

One of the largest and most rigorous clinical trials to test ivermectin as a COVID-19 treatment has just published its results.

South australiaNew south walesUnited kingdomMinas geraisGold coastCraig raynerDonald trumpPaul glasziouThomas borodyChris butlerAndrew mclachlanEd mills at mcmaster university in ontarioCritical care allianceUniversity of sydneyNew england journalFront line

Medical research and funding from big pharma in Australia - researchers fail to declare conflict of interest

A study into the link between money and medical research has found undeclared payments to researchers averaged about $9000 – while some payments from drug companies were up to $97,600.

United statesWendy lipmanRay moynihanPaul glasziouMacquarie universityInternational committee of medical journal editorsBond universityMedicines australiaElizabeth de somerInternational committeeMedical journal editorsProfessor paul

Medical research and funding from big pharma in Australia - researchers fail to declare conflict of interest

A study into the link between money and medical research has found undeclared payments to researchers averaged about $9000 – while some payments from drug companies were up to $97,600.

United statesWendy lipmanRay moynihanPaul glasziouMacquarie universityInternational committee of medical journal editorsBond universityMedicines australiaElizabeth de somerInternational committeeMedical journal editorsProfessor paul

vimarsana © 2020. All Rights Reserved.